Coherus Oncology
CHRS
CHRS
103 hedge funds and large institutions have $611M invested in Coherus Oncology in 2018 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% more funds holding
Funds holding: 94 → 103 (+9)
6.53% more ownership
Funds ownership: 85.4% → 91.94% (+6.5%)
Holders
103
Holding in Top 10
1
Calls
$1.99M
Puts
$983K
Top Buyers
| 1 | +$8.87M | |
| 2 | +$6.33M | |
| 3 | +$5.82M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$5.12M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$4.14M |
Top Sellers
| 1 | -$6.1M | |
| 2 | -$5.92M | |
| 3 | -$2.05M | |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$1.62M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.03M |